225 related articles for article (PubMed ID: 24567419)
1. Sorbitol dehydrogenase overexpression and other aspects of dysregulated protein expression in human precancerous colorectal neoplasms: a quantitative proteomics study.
Uzozie A; Nanni P; Staiano T; Grossmann J; Barkow-Oesterreicher S; Shay JW; Tiwari A; Buffoli F; Laczko E; Marra G
Mol Cell Proteomics; 2014 May; 13(5):1198-218. PubMed ID: 24567419
[TBL] [Abstract][Full Text] [Related]
2. A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker.
Besson D; Pavageau AH; Valo I; Bourreau A; Bélanger A; Eymerit-Morin C; Moulière A; Chassevent A; Boisdron-Celle M; Morel A; Solassol J; Campone M; Gamelin E; Barré B; Coqueret O; Guette C
Mol Cell Proteomics; 2011 Dec; 10(12):M111.009712. PubMed ID: 21986994
[TBL] [Abstract][Full Text] [Related]
3. Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis.
Uzozie AC; Selevsek N; Wahlander A; Nanni P; Grossmann J; Weber A; Buffoli F; Marra G
Mol Cell Proteomics; 2017 Mar; 16(3):407-427. PubMed ID: 28062797
[TBL] [Abstract][Full Text] [Related]
4. Proteome analysis of formalin-fixed paraffin-embedded colorectal adenomas reveals the heterogeneous nature of traditional serrated adenomas compared to other colorectal adenomas.
Sohier P; Sanson R; Leduc M; Audebourg A; Broussard C; Salnot V; Just PA; Pasmant E; Mayeux P; Guillonneau F; Romagnolo B; Perret C; Terris B
J Pathol; 2020 Mar; 250(3):251-261. PubMed ID: 31729028
[TBL] [Abstract][Full Text] [Related]
5. Interplay between post-translational cyclooxygenase-2 modifications and the metabolic and proteomic profile in a colorectal cancer cohort.
Prieto P; Jaén RI; Calle D; Gómez-Serrano M; Núñez E; Fernández-Velasco M; Martín-Sanz P; Alonso S; Vázquez J; Cerdán S; Peinado MÁ; Boscá L
World J Gastroenterol; 2019 Jan; 25(4):433-446. PubMed ID: 30700940
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive look at transcription factor gene expression changes in colorectal adenomas.
Vonlanthen J; Okoniewski MJ; Menigatti M; Cattaneo E; Pellegrini-Ochsner D; Haider R; Jiricny J; Staiano T; Buffoli F; Marra G
BMC Cancer; 2014 Jan; 14():46. PubMed ID: 24472434
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome profile of human colorectal adenomas.
Sabates-Bellver J; Van der Flier LG; de Palo M; Cattaneo E; Maake C; Rehrauer H; Laczko E; Kurowski MA; Bujnicki JM; Menigatti M; Luz J; Ranalli TV; Gomes V; Pastorelli A; Faggiani R; Anti M; Jiricny J; Clevers H; Marra G
Mol Cancer Res; 2007 Dec; 5(12):1263-75. PubMed ID: 18171984
[TBL] [Abstract][Full Text] [Related]
8. The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.
O'Dwyer D; Ralton LD; O'Shea A; Murray GI
PLoS One; 2011; 6(11):e27718. PubMed ID: 22125622
[TBL] [Abstract][Full Text] [Related]
9. Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.
Knol JC; de Wit M; Albrethsen J; Piersma SR; Pham TV; Mongera S; Carvalho B; Fijneman RJ; Meijer GA; Jiménez CR
Biochim Biophys Acta; 2014 May; 1844(5):1034-43. PubMed ID: 24361553
[TBL] [Abstract][Full Text] [Related]
10. Identification and Verification of Two Novel Differentially Expressed Proteins from Non-neoplastic Mucosa and Colorectal Carcinoma Via iTRAQ Combined with Liquid Chromatography-Mass Spectrometry.
Bai Y; Wang J; Gao Z; Dai E
Pathol Oncol Res; 2020 Apr; 26(2):967-976. PubMed ID: 30927204
[TBL] [Abstract][Full Text] [Related]
11. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
12. The polyol pathway and nuclear ketohexokinase A signaling drive hyperglycemia-induced metastasis of gastric cancer.
Kang YL; Kim J; Kwak SB; Kim YS; Huh J; Park JW
Exp Mol Med; 2024 Feb; 56(1):220-234. PubMed ID: 38200154
[TBL] [Abstract][Full Text] [Related]
13. Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.
Bartley AN; Parikh N; Hsu CH; Roe DJ; Buckmeier JA; Corley L; Phipps RA; Gallick G; Lance P; Thompson PA; Hamilton SR
Cancer Prev Res (Phila); 2013 Nov; 6(11):1162-70. PubMed ID: 24008128
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
[TBL] [Abstract][Full Text] [Related]
15. Fructose Metabolism in Cancer.
Krause N; Wegner A
Cells; 2020 Dec; 9(12):. PubMed ID: 33302403
[TBL] [Abstract][Full Text] [Related]
16. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
17. Identification of key players for colorectal cancer metastasis by iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620 cell lines.
Ghosh D; Yu H; Tan XF; Lim TK; Zubaidah RM; Tan HT; Chung MC; Lin Q
J Proteome Res; 2011 Oct; 10(10):4373-87. PubMed ID: 21854069
[TBL] [Abstract][Full Text] [Related]
18. Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
de Wit M; Jimenez CR; Carvalho B; Belien JA; Delis-van Diemen PM; Mongera S; Piersma SR; Vikas M; Navani S; Pontén F; Meijer GA; Fijneman RJ
Gut; 2012 Jun; 61(6):855-64. PubMed ID: 21890811
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
Gui X; Iacucci M; Ghosh S
Pathol Res Pract; 2020 Nov; 216(11):153211. PubMed ID: 32979687
[TBL] [Abstract][Full Text] [Related]
20. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
